Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria

References

• Cuzon G, Bentchouala C, Vogel A, et al. First outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Constantine, Algeria. Int J Antimicrob Agents. 2015;46(6):725–727.
   PubMed Web of Science ®Google Scholar
• Mellouk FZ, Bakour S, Meradji S, et al. First detection of VIM-4-producing Pseudomonas aeruginosa and OXA-48-producing Klebsiella pneumoniae in Northeastern (Annaba, Skikda) Algeria. Microb Drug Resist. 2017;23(3):335–344.
   PubMed Web of Science ®Google Scholar
• Djahmi N, Dunyach-Remy C, Pantel A, Dekhil M, Sotto A, Lavigne JP. Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries. Biomed Res Int. 2014;2014:305784.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791–1798.
   PubMed Web of Science ®Google Scholar
• Hays C, Benouda A, Poirel L, Elouennass M, Nordmann P. Nosocomial occurrence of OXA-48-producing enterobacterial isolates in a Moroccan hospital. Int J Antimicrob Agents. 2012;39(6):545–547.
   PubMed Web of Science ®Google Scholar
• Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012;67(6):1597–1606.
   PubMedGoogle Scholar
• Bakour S, Olaitan AO, Ammari H, et al. Emergence of colistin- and carbapenem-resistant Acinetobacter baumannii ST2 clinical isolate in Algeria: first case report. Microb Drug Resist. 2015;21(3):279–285.
   PubMed Web of Science ®Google Scholar
• Agabou A, Pantel A, Ouchenane Z, et al. First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria. Eur J Clin Microbiol Infect Dis. 2014;33(9):1641–1646.
   PubMed Web of Science ®Google Scholar
• Sefraoui I, Berrazeg M, Drissi M, Rolain JM. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012. Microb Drug Resist. 2014;20(2):156–161.
   PubMed Web of Science ®Google Scholar
• Lee JY, Ko KS. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-beta-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int J Antimicrob Agents. 2012;40(2):168–172.
   PubMed Web of Science ®Google Scholar
• Antibiogram Committee of the French Society for Microbiology/European Committee for Antimicrobial Susceptibility Testing. CA-SFM/Eucast. 2015- Version 1.0. Available from: http://www.sfm-microbiologie.org/UserFiles/files/casfm/CASFM_EUCAST_V1_2015.pdf
   Google Scholar
• Bakour S, Garcia V, Loucif L, et al. Rapid identification of carbapenemase-producing Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii using a modified Carba NP test. New Microbes New Infect. 2015;7:89–93.
   PubMedGoogle Scholar
• Yagoubat M, Ould El-Hadj-Khelil A, Malki A, et al. Genetic characterisation of carbapenem-resistant Gram-negative bacteria isolated from the University Hospital Mohamed Boudiaf in Ouargla, southern Algeria. J Glob Antimicrob Resist. 2017;8:55–59.
   PubMed Web of Science ®Google Scholar
• Agabou A, Lezzar N, Ouchenane Z, et al. Clonal relationship between human and avian ciprofloxacin-resistant Escherichia coli isolates in North-Eastern Algeria. Eur J Clin Microbiol Infect Dis. 2016;35(2):227–234.
   PubMed Web of Science ®Google Scholar
• Mathlouthi N, Al-Bayssari C, Bakour S, et al. Prevalence and emergence of carbapenemases-producing Gram-negative bacteria in Mediterranean basin. Crit Rev Microbiol. 2017;43(1):43–61.
   PubMed Web of Science ®Google Scholar
• Aggoune N, Tali-Maamar H, Assaous F, Benamrouche N, Naim M, Rahal K. Emergence of plasmid mediated carbapenemase OXA-48 in a Klebsiella pneumoniae strain in Algeria. J Glob Antimicrob Resist. 2014;2(4):327–329.
   PubMed Web of Science ®Google Scholar
• Bouguenoun W, Bakour S, Bentorki AA, Al Bayssari C, Merad T, Rolain JM. Molecular epidemiology of environmental and clinical carbapenemase-producing Gram-negative bacilli from hospitals in Guelma, Algeria: multiple genetic lineages and first report of OXA-48 in Enterobacter cloacae. J Glob Antimicrob Resist. 2016;7:135–140.
   PubMed Web of Science ®Google Scholar
• Loucif L, Kassah LA, Saidi M, Messala A, Chelaghma W, Rolain JM. Outbreak of OXA-48-producing Klebsiella pneumoniae involving an ST 101 clone in Batna University Hospital, Algeria. Antimicrob Agents Chemother. 2016;60(12):7494–7497.
   PubMed Web of Science ®Google Scholar
• Jakobsen L, Kurbasic A, Skjøt-Rasmussen L, et al. Escherichia coli isolates from broiler chicken meat, broiler chickens, pork, and pigs share phylogroups and antimicrobial resistance with community-dwelling humans and patients with urinary tract infection. Foodborne Pathog Dis. 2010;7(5):537–547.
   PubMed Web of Science ®Google Scholar
• Zurfluh K, Nuesch-Inderbinen MT, Poirel L, Nordmann P, Hächler H. Emergence of Escherichia coli producing OXA-48 beta-lactamase in the community in Switzerland. Antimicrob Resist Infect Control. 2015;4:9.
   PubMed Web of Science ®Google Scholar
• Barguigua A, El Otmani F, Talmi M, Zerouali K, Timinouni M. Emergence of carbapenem-resistant Enterobacteriaceae isolates in the Moroccan community. Diagn Microbiol Infect Dis. 2012;73(3):290–291.
   PubMed Web of Science ®Google Scholar
• Yousfi M, Touati A, Mairi A, et al. Emergence of carbapenemase-producing Escherichia coli isolated from companion animals in Algeria. Microb Drug Resist. 2016;22(4):342–346.
   PubMed Web of Science ®Google Scholar
• Liu X, Thungrat K, Boothe DM. Occurrence of OXA-48 carbapenemase and other beta-lactamase genes in ESBL-producing multidrug resistant Escherichia coli from dogs and cats in the United States, 2009–2013. Front Microbiol. 2016;7:1057.
   PubMed Web of Science ®Google Scholar
• Pantel A, Richaud-Morel B, Cazaban M, Bouziges N, Sotto A, Lavigne JP. Environmental persistence of OXA-48-producing Klebsiella pneumoniae in a French intensive care unit. Am J Infect Control. 2016; 44(3):366–368.
   PubMed Web of Science ®Google Scholar
• Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol. 2016;7:895.
   PubMed Web of Science ®Google Scholar
• Kocsis B, Kocsis E, Fontana R, Cornaglia C, Mazzariol A. Identification of blaLAP-(2) and qnrS1 genes in the internationally successful Klebsiella pneumoniae ST147 clone. J Med Microbiol. 2013;62(Pt 2):269–273.
   PubMedGoogle Scholar
• Lee SY, Park YJ, Yu JK, et al. Prevalence of acquired fosfomycin resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J Antimicrob Chemother. 2012;67(12):2843–2847.
   PubMed Web of Science ®Google Scholar
• Luo Y, Wang Y, Ye L, Yang J. Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China. Clin Microbiol Infect. 2014;20(11):O818–O824.
   PubMed Web of Science ®Google Scholar
• Chen Y, Sun J, Liao XP, et al. Impact of enrofloxacin and florfenicol therapy on the spread of OqxAB gene and intestinal microbiota in chickens. Vet Microbiol. 2016;192:1–9.
   PubMed Web of Science ®Google Scholar
• Huber H, Zweifel C, Wittenbrink MM, Stephan R. ESBL-producing uropathogenic Escherichia coli isolated from dogs and cats in Switzerland. Vet Microbiol. 2013;162(2–4):992–996.
   PubMed Web of Science ®Google Scholar
• Mesli E, Berrazeg M, Drissi M, Beckhoucha SN, Roulain JP. Prevalence of carbapenemase-encoding genes including New Delhi metallo-beta-lactamase in Acinetobacter species, Algeria. Int J Infect Dis. 2013;17(9):e739–e743.
   PubMed Web of Science ®Google Scholar
• Touati M, Diene SM, Racherache A, Dekhil M, Djahoudi A, Rolain JM. Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Int J Antimicrob Agents. 2012;40(1):89–91.
   PubMed Web of Science ®Google Scholar
• Viana GF, Zago MC, Moreira RR, et al. ISAba1/blaOXA-23: a serious obstacle to controlling the spread and treatment of Acinetobacter baumannii strains. Am J Infect Control. 2016;44(5):593–595.
   PubMed Web of Science ®Google Scholar
• Pailhoriès H, Belmonte O, Kempf M, et al. Diversity of Acinetobacter baumannii strains isolated in humans, companion animals, and the environment in Reunion Island: an exploratory study. Int J Infect Dis. 2015; 37:64–69.
   PubMed Web of Science ®Google Scholar
• Bakour S, Alsharapy SA, Touati A, Rolain JM. Characterization of Acinetobacter baumannii clinical isolates carrying bla(OXA-23) carbapenemase and 16S rRNA methylase armA genes in Yemen. Microb Drug Resist. 2014;20(6):604–609.
   PubMed Web of Science ®Google Scholar
• Al Bayssari C, Diene SM, Loucif L, et al. Emergence of VIM-2 and IMP-15 carbapenemases and inactivation of oprD gene in carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Lebanon. Antimicrob Agents Chemother. 2014;58(8):4966–4970.
   PubMed Web of Science ®Google Scholar
• Zowawi HM, Ibrahim E, Syrmis MW, Wailan AM, AbdulWahab A, Paterson DL. PME-1-producing Pseudomonas aeruginosa in Qatar. Antimicrob Agents Chemother. 2015;59(6):3692–3693.
   PubMed Web of Science ®Google Scholar